|
|
|
Insider
Information: |
Altshuler David |
Relationship: |
EVP, Chief Scientific... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
25,813 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$12,136,756 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
25,813 |
|
|
Total
Value |
$12,136,756 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Scientific... |
2024-05-15 |
25,813 |
2014-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2022-02-10 |
4 |
D |
$237.74 |
$836,369 |
D/D |
(3,518) |
62,179 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2022-02-17 |
4 |
D |
$232.51 |
$799,602 |
D/D |
(3,439) |
53,999 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2022-02-24 |
4 |
D |
$227.86 |
$1,375,819 |
D/D |
(6,038) |
43,649 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2023-02-10 |
4 |
D |
$294.33 |
$1,018,676 |
D/D |
(3,461) |
65,184 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2023-02-13 |
4 |
D |
$298.26 |
$1,786,577 |
D/D |
(5,990) |
59,194 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2023-02-17 |
4 |
D |
$292.85 |
$1,098,188 |
D/D |
(3,750) |
44,248 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2023-02-24 |
4 |
D |
$289.12 |
$1,147,806 |
D/D |
(3,970) |
36,276 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2024-02-09 |
4 |
D |
$422.74 |
$887,331 |
D/D |
(2,099) |
50,733 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2024-02-16 |
4 |
D |
$424.01 |
$1,590,038 |
D/D |
(3,750) |
43,838 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2024-02-20 |
4 |
D |
$420.58 |
$1,182,671 |
D/D |
(2,812) |
41,026 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2024-02-23 |
4 |
D |
$431.79 |
$1,714,206 |
D/D |
(3,970) |
30,052 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-07-31 |
4 |
OE |
$59.55 |
$297,750 |
D/D |
5,000 |
5,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-05 |
4 |
OE |
$59.55 |
$148,875 |
D/D |
2,500 |
2,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-19 |
4 |
OE |
$59.55 |
$297,750 |
D/D |
5,000 |
5,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-24 |
4 |
OE |
$59.55 |
$148,875 |
D/D |
2,500 |
2,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-29 |
4 |
OE |
$59.55 |
$148,875 |
D/D |
2,500 |
2,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-01 |
4 |
OE |
$63.14 |
$668,968 |
D/D |
10,595 |
10,595 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-06 |
4 |
OE |
$63.14 |
$88,712 |
D/D |
1,405 |
1,405 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-28 |
4 |
OE |
$63.14 |
$126,280 |
D/D |
2,000 |
2,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-11-28 |
4 |
OE |
$59.55 |
$212,015 |
D/D |
3,500 |
3,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2015-11-18 |
4 |
OE |
$63.14 |
$1,014,600 |
D/D |
15,000 |
90,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2015-12-01 |
4 |
OE |
$72.14 |
$360,700 |
D/D |
5,000 |
80,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2017-04-28 |
4 |
OE |
$63.14 |
$473,550 |
D/D |
7,500 |
113,511 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2017-06-05 |
4 |
OE |
$72.14 |
$541,050 |
D/D |
7,500 |
113,511 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2017-07-19 |
4 |
OE |
$81.54 |
$2,448,338 |
D/D |
28,979 |
134,990 |
0 |
- |
|
157 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|